KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Goodwill (2021 - 2025)

Pacific Biosciences Of California (PACB) has 5 years of Goodwill data on record, last reported at $317.8 million in Q4 2025.

  • For Q4 2025, Goodwill changed N/A year-over-year to $317.8 million; the TTM value through Dec 2025 reached $317.8 million, changed N/A, while the annual FY2025 figure was $317.8 million, N/A changed from the prior year.
  • Goodwill reached $317.8 million in Q4 2025 per PACB's latest filing, roughly flat from $317.8 million in the prior quarter.
  • Across five years, Goodwill topped out at $463.8 million in Q3 2023 and bottomed at $317.8 million in Q1 2025.
  • Average Goodwill over 5 years is $398.7 million, with a median of $410.0 million recorded in 2021.
  • Peak YoY movement for Goodwill: rose 13.14% in 2023, then crashed 31.26% in 2025.
  • A 5-year view of Goodwill shows it stood at $410.0 million in 2021, then increased by 0.01% to $410.0 million in 2022, then grew by 12.75% to $462.3 million in 2023, then decreased by 20.16% to $369.1 million in 2024, then decreased by 13.9% to $317.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $317.8 million in Q4 2025, $317.8 million in Q2 2025, and $317.8 million in Q1 2025.